Parkinson Research Foundation
  • ABOUT US
    • About Us
    • Our Team
    • Medical Leadership
  • PD AND YOU
    • PD 101
      • What is PD?
      • Who is more likely to get PD
      • How is PD diagnosed and treated
    • PD Update
      • 2024
        • Summer
        • Spring
        • Winter
      • 2023
        • Fall
        • Summer
        • Spring
        • Winter
    • PD Terms
    • In The News
  • DONATE
    • Ways to Donate
    • Donate Now!
    • Financials
    • Donor Bill Of Rights
    • Privacy
  • CONTACT
Select Page

Financials

2023 Financial Statements:

 

Independent Audit
PRF 990

2022 Financial Statements:

 

Independent Audit
PRF 990

2021 Financial Statements:

 

Independent Audit
PRF 990

2020 Financial Statements:

 

Independent Audit
PRF 990

THE PARKINSON RESEARCH FOUNDATION, INC. IS A REGISTERED 501(C)(3) NON-PROFIT CORPORATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN THE STATE (1-800-HELP-FLA) OR ON THE CONSUMER SERVICES WEBSITE WWW.800HELPFLA.COM. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.

VISIT US

5969 CATTLERIDGE BLVD. SUITE 100
SARASOTA, FL 34232

CALL US

(941) 870-4438

NEWS

  • Higher levels of plasma phosphatidylcholine (17:0_18:1) raise the risk of developing Parkinson’s disease - Nature
  • Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease - The Manila Times
  • Persistence Market Research Projects Parkinson's Disease Drugs Market to Reach US$ 13.3 Billion by 2032 - openPR.com
  • Facebook
  • X
© 2018 Parkinson Research Foundation. All Rights Reserved.